Pruritus in hemodialysis patients by Akhyani, Maryam et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Dermatology
Open Access Research article
Pruritus in hemodialysis patients
Maryam Akhyani1, Mohammad-Reza Ganji2, Nasrin Samadi3, 
Behnaz Khamesan4 and Maryam Daneshpazhooh*1
Address: 1Department of dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran, 2Department of nephrology, Tehran 
University of Medical Sciences, Dr. Shariati hospital, Tehran, Iran, 3Department of pathology, Tehran University of Medical Sciences, Sina hospital, 
Tehran, Iran and 4Department of pediatrics, Iran University of Medical Sciences, Hazrat Rasool Hospital, Tehran, Iran
Email: Maryam Akhyani - ma_akhyani@yahoo.com; Mohammad-Reza Ganji - mreza@ganji.ir; Nasrin Samadi - nasrinmd@parsonline.net; 
Behnaz Khamesan - behnazkhamesan@yahoo.com; Maryam Daneshpazhooh* - maryamdanesh@yahoo.com
* Corresponding author    
Abstract
Background: Pruritus is one of the most bothersome symptoms in patients on maintenance
hemodialysis (HD), however little progress is seen in our understanding of its pathogenesis. The
aim of this study was to evaluate the frequency of pruritus in HD patients in Tehran, Iran, and to
correlate its presence and intensity with relevant clinical and laboratory parameters.
Methods: One hundred sixty-seven patients on maintenance HD at three out-patient HD units
were enrolled in the study. Itch intensity was scored as mild, moderate and severe. Some relevant
clinical and laboratory parameters (age, sex, xerosis, presence of neuropathy, duration of dialysis,
history of atopy and laboratory findings including hematocrit, creatinine, urea, calcium, phosphorus,
parathyroid hormone [PTH] and alkaline phosphatase) were evaluated.
Results: Pruritus was found in 41.9% of patients. The intensity of itching was mild, moderate and
severe, in 51.4%, 11.4% and 37.7% of patients, respectively. In 22 patients (31.4%) pruritus
intensified during and after dialysis. There was no significant difference in the serum levels of
creatinine, blood urea nitrogen, calcium, phosphorus, alkaline phosphatase, PTH and hematocrit
between patients with and without pruritus. Age, sex, xerosis, underlying renal disease, history of
atopy and duration of haemodialysis were not significantly different between the two groups.
However, neuropathy was significantly more common in the pruritic group (63.8% versus 42.1%)
(pv = 0.006).
Conclusion: Clinical neuropathy was the only significant finding in the pruritic group in our study.
This finding justifies further research on nerve function and neurotransmitters in hemodialysis
patients and the introduction of new drugs targeting neuropathy.
Background
Pruritus often constitutes a major problem for patients
with end-stage renal disease (ESRD). Unfortunately, dial-
ysis has only a slight impact on pruritus. Therefore it is
quite frustrating that an ever-increasing number of ESRD
patients on HD, are waiting for transplantation, while
they suffer from this tormenting symptom. According to
most sources, more than half of patients undergoing HD
complain of varying degrees of pruritus. [1-4] The mecha-
nism underlying pruritus is poorly understood; current
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theories include secondary hyperparathyroidism, diva-
lent-ion abnormalities, histamine, allergic sensitization,
proliferation of skin mast cells, iron deficiency anemia,
hypervitaminosis A, xerosis, neuropathy and neurologic
changes, opioid system involvement (understimulation
of κ  receptors or overexpression of µ receptors), cytokines,
serum bile acids, nitric oxide, or some combination of
these.[1,4-12] The quality of uremic pruritus varies
between patients. In some it is persistent, extensive and
intractable but in others it may be transitory and local-
ized. [1] Pruritus usually begins about six months after the
start of dialysis, [13] and some authors have shown a sig-
nificant positive relationship with the duration of HD.
[10] The aim of this study was to evaluate the frequency of
pruritus in hemodialysis patients in Tehran, Iran, and its
relationship with age, sex, xerosis, neuropathy, duration
of dialysis, history of atopy and laboratory findings
including hematocrit, creatinine, urea, calcium, phospho-
rus, alkaline phosphatase and PTH.
Methods
All patients (n = 167)on maintenance HD attending three
HD units at Emam Khomeini, Dr Shariati and Sina Medi-
cal Complexes in Tehran, Iran, from 1998–1999 were
enrolled in a cross-sectional study. Eighty-three were men
and 84 were women. Their mean age was 47.95 +/-16.73
years with a range of 10–76 years. The routine of dialysis
was 3 times per week (except holidays) for 4 hours. The
mean of dialysis sessions per week are presented in table
1. Polysulfone membranes were used as dialyser, the dia-
lysate was mainly acetate, and sodium hypochlorite was
used for sterilization. Twenty nine of the patients were
diabetic, while four patients suffered from systemic lupus
erythematosus (SLE), two from lymphoma and one from
multiple myeloma. The etiology in the remaining cases
was unknown. None of the patients presented with pri-
mary skin disease.
The patients were questioned, by a physician, if they had
pruritus during the previous two weeks, and the symp-
toms were classified according to intensity (mild, moder-
ate, and severe), location (generalized, head and neck,
trunk and limbs), type of pruritus (episodic, persistence)
and duration of HD. The patients' symptoms were
recorded before a mid-week HD session and a blood sam-
ple was collected. The following laboratory tests were per-
formed: Serum calcium, phosphorus, alkaline
phosphatase, PTH, BUN, creatinine and hematocrit.
Measurement of pruritus
The severity of pruritus was assessed subjectively and
scored as follows:
Mild: Episodic and localized pruritus without disturbance
in usual work and sleep.
Moderate: Generalized and continuous pruritus without
sleep disturbance.
Severe: Generalized and continuous pruritus with sleep
disturbance.
The major emphasis was on the disturbance in usual work
and sleep.
Grading of xerosis
Xerosis was graded as follows:
0: Absent; 1: Mild (only on legs); 2: Moderate (all of the
extremities); and 3: Severe (generalized).
Neuropathy
The diagnosis of clinical neuropathy was based on the
presence of paresthesia, restless leg syndrome, decreased
sensations of vibration, position, light touch, pain,
decreased deep tendon reflexes or muscular force.
Table 1: Comparison of clinical and laboratory parameters in HD patients
Clinical & laboratory parameters Pruritic (mean ± SD) Non pruritic (mean ± SD) p-value
Age (years) 51.54 ± 16.63 45.37 ± 16.41 0.1212
Time on treatment (months) 44.42 ± 44 41.41 ± 44.73 0.666
Dialysis per week 2.6 ± 0.55 2.57 ± 0.59 0.682
Hematocrit (%) (M = 39–52)(F = 36–46) 25.43 ± 6.99 24.95 ± 5.43 0.647
Serum calcium (mg/dl) (8.6–10.3) 8.705 ± 1.79 8.707 ± 1.44 0.994
Serum phosphorus (mg/dl) (2.7–4.5) 5.45 ± 1.72 5.74 ± 1.66 0.314
Serum alkaline phosphatase (u/l) (150–450 u/l) 322.01 ± 272.61 494.56 ± 750.76 0.080
BUN (mg/dl) (8–20) 131.31 ± 66.01 136.08 ± 68.61 0.673
Serum creatinine (mg/dl) (0.4–1.3) 9.43 ± 3.21 9.27 ± 3.29 0.777
Parathyroid hormone (pmole/l)(0.8–2.5) 0.9 ± 1.16 1.43 ± 0.85 0.252BMC Dermatology 2005, 5:7 http://www.biomedcentral.com/1471-5945/5/7
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Definition of atopy
Positive history of asthma, atopic dermatitis (based on
Hanifin-Rajka criteria [14]) or allergic rhinitis was defined
as atopy.
Statistical analysis
Pruritus and non-pruritus groups were compared accord-
ing to the variables. Data entry and coding was done
through a database system developed with PE2 and ana-
lyzed by SPSS version 9. Student t-test and X2 score were
used for statistical analysis. Statistical significance was
defined as p < 0.05.
Results
Seventy patients (41.9%) (30 women and 40 men) com-
plained of pruritus classified as mild, moderate and severe
in 51.4% (n = 36), 11.4% (n = 8) and 37.1% (n = 26) of
patients, respectively. The difference between the fre-
quency of pruritus by gender was not significant (pv >
0.05). Pruritus was episodic in 60% (n = 42) and persist-
ent in 40%(n = 28) of patients. Six patients had episodic
but generalized pruritus with disturbance in work or sleep
and their itch was categorized as moderate or severe. In
31.4% (n = 22) of patients pruritus intensified during and
after dialysis.
Pruritus was generalized in 70 %(n = 49) of patients, lim-
ited to the trunk in 14.3% (n = 10), limbs 14.3% (n = 10),
and head and neck 1.4 %(n = 1). There was history of
atopy in 17 (24.3%) of pruritic and 20 (20.6%) of non-
pruritic patients. The difference was not significant (pv >
0.05). Nine out of 21 diabetic patients, one out of 4 SLE
patients and one lymphomatous patient complained of
pruritus. There was no statistically significant difference
between pruritus in diabetic and non-diabetic subjects (pv
> 0.05). Forty seven out of 97 non-pruritic patients had a
past history of pruritus during HD treatment. Comparison
of clinical and laboratory parameters in HD patients with
and without pruritus is shown in table 1. There was no sig-
nificant difference among the two groups using t-test (pv
> 0.05).
There wasn't any relationship between pruritus and xero-
sis in HD patients 2. Pruritus was alleviated in one patient
after parathyroidectomy.
Eighty-four patients (51.3%) suffered from peripheral
neuropathy (Three patients with diabetic foot amputation
were excluded). Fifty-eight had only subjective symptoms;
decreased sensation of vibration, decreased deep tendon
reflexes, decreased pain perception, decreased sensation
of light touch, and decreased sensation of position were
noted in 19, 11, 7, 5, and 4 cases, respectively. In the pru-
ritic group, 44 patients (63.8%), and in the non-pruritic
group, 40 cases (42.1%) had neuropathy. The difference
was significant (p-value = 0.006).
Discussion
Pruritus is one of the most prevalent presentations of ure-
mia and occurs in 10–85% of HD patients. [1,15-17] Dif-
ficulty in defining this very subjective symptom, the
limited number of patients in most series, and the retro-
spective nature of some of the information, may be some
of the reasons why such a wide range of figures is quoted.
Recently, Urbonas et al noticed a decreasing trend in the
prevalence of pruritus in HD patients and attributed it to
more precise calculation of HD doses based on Kt/v or cre-
atinine clearance measurements, introduction of new dia-
lysers with larger surfaces as well as replacement of
cuprophane fibers to more biocompatible ones made
from polysulfone and amyl nitrite. [1,10,18]
Despite the long history of HD in Iran, to the best of our
knowledge no study is published in the literature
regarding the itch in Iranian HD patients. In our study,
including 167 patients, pruritus was found in 41.9% of
patients, severe in 37.1%, moderate in 11.4%, and mild in
51.4% of pruritic patients. Stahle-Backdahl et al,
described pruritus in 60–65% of their cases which was
severe in 8%, moderate in 24%, and mild in 34% of the
examined patients. [19] Zucker and his colleagues
reported pruritus in 48% of their HD patients at the time
of the study in Tel-Aviv. [20] The figure reported from
Poland by Szepietowski et al was 40.8% [10,21]. In Kato's
series from Japan, 74% complained of pruritus [11].
Benchikhi et al reported a figure of 74.4% in HD patients
from Moroc [22]. It is worth mentioning that a major
drawback for studying and comparing results from differ-
ent studies is the lack of a uniform way for assessment of
this very subjective symptom. Recently, Yosipovitch et al
has developed a comprehensive questionnaire for the
assessment of pruritus and tested it in uremic patients and
found it valid and reliable [23]. This questionnaire can
provide data on many aspects of itching: the effect of daily
life habits, physical activities and antipruritics on itch, the
effect of itch on quality of life, temporal factors, location,
Table 2: Frequency of pruritus in HD patients according to 
severity of xerosis
Xerosis Pruritic Non pruritic
Absent 27 (38.6%) 33 (34%)
Mild 19 (27.1%) 40 (41.2%)
Moderate 19 (27.1%) 18 (18.6%)
Severe 5 (07.1%) 6 (06.2%)
Total 70 (100%) 97 (100%)
X2 pv = 0.26BMC Dermatology 2005, 5:7 http://www.biomedcentral.com/1471-5945/5/7
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severity, characteristics and exacerbating and relieving fac-
tors are all included. They found a significant correlation
between the visual analogue scale and affective scores.
Uremic pruritus may be constant in 50% of cases with
exacerbation or intermittent with spontaneous remis-
sions. [24] In the majority of those affected, the itch is par-
oxysmal and may be localized (56%) or generalized
(44%).[25] Seventy percent of our patients suffered from
generalized pruritus as Moroccan patients.[22] Exacerba-
tions of continuous itch are usually observed during HD
or soon after, [1] which can be attributed to allergy to dia-
lysate or dialysis membranes. [18] Exacerbation of pruri-
tus during dialysis sessions was seen in 31.4% of HD
patients in our study. In Yosipovitch series, too, itch
appeared or aggravated in only 26% of patients during
dialysis and the majority did not note an effect of dialysis
on their itch. [23]
In Stahle-Backdahl et al's study, patients with pruritus
tended to have been on dialysis treatment longer than
those without pruritus.[2] Szepietowski et al showed a sig-
nificant relationship between the total score of pruritus
and duration of hemodialysis.[10] On the contrary, Alt-
meyer et al [26] described a significant improvement of
itching in patients who had been on HD for long period
of time: of the 23 patients with short term dialysis (2–3
years), 78% complained of pruritus, while it was seen in
only 43% of 28 patients with long-term dialysis (>8
years). Murphy et al [27], however, could not confirm that
pruritus decreases with progressive duration of dialysis
treatment. In our study, we did not find any relationship
between pruritus and duration of dialysis as seen in some
previous studies. [7,19,26,27]
Xerosis is seen in the majority of patients on HD [1,4,7,8]
and it may contribute to pruritus. [1,7,10,11,20] A rela-
tionship between the degree of xerosis and pruritus has
been demonstrated in several studies, [1,10,20,28,29]
although others failed to find an association between skin
hydration and pruritus using a skin surface hygrometer.
[11,30,31] Xerosis found in HD patients has been attrib-
uted to increased level of vitamin A in epidermis, atrophy
of sebaceous and sweat glands and dysautonomia.
[1,7,15] In our study the prevalence of xerosis in pruritic
and non-pruritic patients was 61.4% and 66%, respec-
tively, and we couldn't find any association between xero-
sis and pruritus.
Increased serum levels of magnesium, phosphorus and
calcium have been proposed to be involved in uremic pru-
ritus by some authors. [1,9,15,24] It has been suggested
that an increased skin divalent ions concentration may
lead to microprecipitation of calcium or magnesium
phosphate, which may be the cause of pruritus. [1] On the
other hand, the role of magnesium itself in the modula-
tion of nerve conduction and release of histamine from
mast cells was put forward. [1] While marked improve-
ment of uremic pruritus with low dialysate calcium and
magnesium has been reported [32,33], only a few studies
showed a significant correlation between serum or skin
divalent ion content and the presence of pruritus.[1,6]
Recently, Momose et al, found increased calcium ion con-
centration in the deepest layers of the epidermis indicat-
ing a disrupted calcium ion gradient in the skin.[6] Like
most studies [3,22,31], we couldn't find any association
between serum calcium and phosphorus and uremic
pruritus.
Hyperparathyroidism has been proposed by some as a
cause of uremic pruritus.[8] Cases of disappearance of
pruritus after parathyroidectomy support this the-
ory.[1,4,8] This hormone can indirectly lead to metabolic
alterations that subsequently cause pruritus.[1] On the
other hand, a direct role for parathyroid hormone in caus-
ing uremic pruritus has been questioned because of the
failure of intradermal injections of PTH analogs to cause
pruritus, and because of negative immunohistochemical
studies for PTH in skin biopsy specimens.[19]
Furthermore, no correlation between PTH levels and
intensity of itching was found in most studies.[1,9,31]
Although pruritus improved after parathyroidectomy in
one of our cases, we couldn't find any relationship
between serum PTH and pruritus in our study.
Iron deficiency anemia contributes to renal itch according
to some authors, but we couldn't find any relationship
between hematocrit level and uremic pruritus as shown in
more recent studies[3,31].
Likewise, we couldn't find any association between HD
pruritus and atopy. No previous research was recorded in
the literature.
In our study there were also no significant difference
between pruritic and non pruritic HD patients according
to age, sex, underlying renal disease, serum alkaline phos-
phatase, BUN and creatinine similar to previous studies.
[1,3,4,11,20-22,31]
Peripheral neuropathy affects up to 65% of patients start-
ing dialysis. Some consider pruritus another manifesta-
tion of this neuropathy.[17] Contradictory data have been
published about neurone-specific enolase fibers in the
epidermis of HD patients. [2,34] Zakrzewska-Pniewska
and Jedras found nervous dysfunction especially the
somatic component related to pruritus in uremic patients.
Pruritus was more frequent in patients with paresthesia in
their study. Moreover the relationship between the sever-BMC Dermatology 2005, 5:7 http://www.biomedcentral.com/1471-5945/5/7
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ity of pruritus and the incidence of paresthesia was signif-
icant. [35]On the other hand, reports showing the efficacy
of lidocaine [36,37], capsaicin [9,38,39], and gabapentin
[40,41] in controlling uremic pruritus are in favor of a
relationship between neuropathy and itching in HD
patients. Yosipovitch et al reported paradoxical heat sen-
sation an early sign of uremic sensory neuropathy. [42]
Neuropathy was significantly more frequent in patients
with pruritus than without in our series, showing a figure
of 63.8% versus 42.1% (pv < 0.05). These findings were
not confounded by the presence of diabetics in the study
group, as pruritus was not significantly different between
diabetics and non-diabetics. Clinical neuropathy was sig-
nificantly more frequent in HD patients with pruritus in
Mesic's cases.[43] Winkelman et al, too, showed correla-
tion between restless legs syndrome and pruritus. [44]
In conclusion, clinical neuropathy was the only signifi-
cant finding in the pruritic group in our study. This find-
ing justifies further research on nerve function and
neurotransmitters in hemodialysis patients. Furthermore,
therapeutic or preventive modalities targeting neuropathy
may be effective in controlling the itch in hemodialysis
patients.
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